Nexgenia: Seattle startup raises $2M to expand technologies for immunotherapy

Take a quick browse through Seattle's biotech scene, and you'll notice a pattern. Immunotherapy - using the body's immune system to fight cancer - is the hottest topic in biotechnology nowadays, and it is dominating Seattle's biotech scene, from research giants like Fred Hutchinson Cancer Research Center to startups like Alpine Immune Sciences. But it is a complex process that requires the handling thousands of cells and molecules, which can be difficult, time consuming, and costly. Enter Nexgenia, a startup whose reagents can sort samples by fishing out certain cells and molecules, a valuable ability in the process of creating immunotherapies. Helmed by CEO Ron Myers, Nexgenia has been employing their... Read More